 prospective double-blind crossover study efficacy safety chronic nifedipine therapy isosorbide dinitrate combination treatment chronic congestive heart failure prospective double-blind crossover study efficacy safety vasodilation calcium entry blocker nifedipine isosorbide dinitrate ISDN combination treatment heart failure Twenty-eight patients New York Heart Association Functional class II III chronic heart failure due left ventricular systolic dysfunction patients constant dose digitalis diuretics study Eight weeks therapy nifedipine alone combination ISDN incidence heart failure deterioration hospitalizations additional diuretics percent patients required hospitalization nifedipine therapy required hospitalization nifedipine-ISDN combination therapy comparison hospitalization ISDN therapy total number heart failure-worsening episodes patients nifedipine patients ISDN versus nifedipine patients nifedipine-ISDN combination versus nifedipine versus ISDN Premature discontinuation drug administration due clinical deterioration side effects patients nifedipine therapy patients ISDN therapy versus nifedipine patients combination therapy comparison patients clinical deterioration nifedipine remainder patients significant difference left ventricular ejection fraction versus maximal oxygen uptake exercise versus ml/kg/min